Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state ...

The authors write "The Food, Drug and Cosmetic Law Section of the New York State Bar Association is delving into the changing ...

Actavis was a generics giant whose rise mirrors the huge growth of off-patent medicines, while Gilead has rocketed into pharma's top 20 biggest companies in 2014 thanks to ground and record ...

The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain ...

AUSTIN, TX / ACCESSWIRE / January 10, 2025 / Aspira Women's Health Inc. ('Aspira' or the 'Company') (Nasdaq:AWH), a bio-analytical based women's health company focused on the development of ...

For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all ...

Whereas Teva Pharmaceutical had north of $35 billion in net debt following its acquisition of Actavis in 2016, it now has less than $15.7 billion in net debt on its balance sheet. With Teva's long ...

The data is taken from the GlobalData Pharma Intelligence Center’s Financials ... including the reverse merger with Actavis. On the profitability side, 10 out of the top 20 companies reported ...

It's settled long-standing opioid litigation, and the company has reduced its net debt from north of $35 billion following the Actavis buyout in 2016 to roughly $15.7 billion, as of the end of ...

It's settled long-standing opioid litigation, and the company has reduced its net debt from north of $35 billion following the Actavis buyout ... invest $1,000 in Teva Pharmaceutical Industries ...

It's settled long-standing opioid litigation, and the company has reduced its net debt from north of $35 billion following the Actavis buyout in 2016 to ... SSR Mining, and Teva Pharmaceutical ...